Microfluidic dissociation and clearance of Alzheimer's β-amyloid aggregates

Biomaterials

Volumn 31, Issue 26, 2010, Pages 6789-6795

  Lee, Joon Seok ^a   Park, Chan Beum ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Amyloid; Dissociation; Metal chelators; Microfluidics; Self assembly

Indexed keywords

ALZHEIMER'S; ALZHEIMER'S DISEASE; AMYLOID PEPTIDES; BEFORE AND AFTER; DEFEROXAMINE; IN-VIVO; METAL CHELATOR; MICROFLUIDIC PLATFORMS; PARALLEL SCREENING; SECONDARY STRUCTURES;

AGGREGATES; CHELATION; DEPOSITS; DISSOCIATION; GLYCOPROTEINS; METAL IONS; METALS; MICROCHANNELS; PROTEINS; SELF ASSEMBLY;

MICROFLUIDICS;

AMYLOID BETA PROTEIN; DEFEROXAMINE; EDETIC ACID; EPIGALLOCATECHIN GALLATE; METAL CHELATE; METAL ION; NITRILOTRIACETIC ACID; PENTETIC ACID; SILIBININ; IRON; IRON CHELATING AGENT; SOLUTION AND SOLUBILITY;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL STRUCTURE; CLEARANCE; DISSOCIATION; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; MICROFLUIDICS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; SCREENING; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; MOLECULAR GENETICS; PROCEDURES; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; SOLUTION AND SOLUBILITY; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; DEFEROXAMINE; HUMANS; IRON; IRON CHELATING AGENTS; MICROFLUIDICS; MICROSCOPY, ATOMIC FORCE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; SOLUTIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; AMYLOID BETA-PEPTIDES;

EID: 77954384174     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.05.033     Document Type: Article

References (29)

1. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi M. Forecasting the global burden of Alzhimer's disease. Alzheimers Dement 2007, 3:186-191.
2. Kammesheidt A., Boyce F.M., Spanoyannis A.F., Cummings B.J., Ortegon B., Cotman C., et al. Deposition of b/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 1992, 89:10857-10861.
3. Murphy R.M. Peptide aggregation in neurodegenerative disease. Annu Rev Biomed Eng 2002, 4:155-174.
4. Istrin G., Bosis E., Solomon B.J. Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-β peptide. Neurosci Res 2006, 84:434-443.
5. Glabe C. Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?. Nat Med 2000, 6:133-134.
6. Miroy G.L., Lai Z., Lashuel H.A., Peterson S.A., Strang C., Kelly J.W. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci USA 1996, 93:15051-15056.
7. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001, 7:369-372.
8. Cowan C.B., Cote G.L., Good T.A. Development of photocrosslinked sialic acid containing polymers for use in Aβ toxicity attenuation. Biomaterials 2008, 29:3408-3414.
9. Mishra R., Winter R. Cold-and pressure-induced dissociation of protein aggregates and amyloid fibrils. Angew Chem Int Ed 2008, 47:6518-6521.
10. Xiao L., Zhao D., Chan W.H., Choi M.M.F., Li H.W. Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots. Biomaterials 2010, 31:91-98.
11. Yanagisawa D., Shirai N., Amatsubo T., Taguchi H., Hirao K., Urushitani M., et al. Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease. Biomaterials 2010, 31:4179-4185.
12. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci 2003, 26:207-214.
13. Liu G., Huang W., Moir R.D., Vanderburg C.R., Lai B., Peng Z., et al. Metal exposure and Alzheimer's pathogenesis. J Struct Biol 2006, 155:45-51.
14. House E., Collingwood J., Khan A., Berthon G., Exley C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzhimer' disease. J Alzheimers Dis 2004, 6:291-301.
15. 2+ binding site in amyloid-β. Biochemistry 2005, 44:5478-5487.
16. Domingo J.L. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. J Alzheimers Dis 2006, 10:331-341.
17. Zhu M., Souillac P.O., Ionescu-Zanetti C., Carter S.A., Fink A.L. Surface-catalyzed amyloid fibril formation. J Biol Chem 2002, 277:50914-50922.
18. Pellarin R., Guarnera E., Caflisch A. A pathways and intermediates of amyloid fibril formation. J Mol Biol 2007, 374:917-924.
19. Girigoswami K., Ku S.H., Ryu J., Park C.B. A synthetic amyloid lawn system for high-throughput analysis of amyloid toxicity and drug screening. Biomaterials 2008, 29:2813-2819.
20. Ha C., Park C.B. Ex situ atomic force microscopy analysis of β-amyloid self-assembly and deposition on a synthetic template. Langmuir 2006, 22:6977-6985.
21. Lee J.S., Ryu J., Park C.B. High-throughput analysis of Alzheimer's β-amyloid aggregation using a microfluidic self-assembly of monomers. Anal Chem 2009, 81:2751-2759.
22. Lee J.S., Um E., Park J.K., Park C.B. Microfluidic self-assembly of insulin monomers into amyloid fibrils on a solid surface. Langmuir 2008, 24:7068-7071.
23. Xia Y., Whitesides G.M. Soft lithography. Angew Chem Int Ed 1998, 37:550-575.
24. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.D., Teplow D.B. Amyloid β-protein (Aβ) assembly: aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci U.S.A 2003, 100:330-335.
25. Boridy S., Takahashi H., Akiyoshi K., Maysinger D. The binding of pullulan modified cholesteryl nanogels to Aβ oliogomers and their suppression of cytotoxcity. Biomaterials 2009, 30:5583-5591.
26. Klebanoff S.J., Waltersdorph A.M., Michel B.R., Rosen H.J. Oxygen based free radical generation by ferrous ions and deferoxamine. Biol Chem 1989, 264:19765-19771.
27. Trouillas P., Marsal P., Svobodova A., Vostalova J., Gazak R., Hrbac J., et al. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A 2008, 112:1054-1063.
28. Miura T., Suzuki K., Takeuchi H. Binding of iron the single tyrosine residue of amyloid β-peptide probed by Raman spectroscopy. J Mol Struct 2001, 598:79-84.
29. Nilsson M.R. Techniques to study amyloid fibril formation in vitro. Methods 2004, 34:151-160.